ABSTRACT: Heterotopic ossification (HO) is the formation of pathological bone in ectopic sites and it can have serious consequences for functional outcomes. For many years, its main clinical relevance was as a rare complication of elective joint arthroplasty or CNS injury and a number of prophylaxes were developed to mitigate against it in these settings. As a consequence of changes in patterns of wounding and survival in conflicts since the turn of the century, post-traumatic HO has become much more common and case severity has increased. It represents one of the main barriers to rehabilitation in a large cohort of combat-injured patients. However, extant prophylaxes have not been shown to be effective or appropriate in this patient cohort. In addition, the lack of reliable early detection or means of predicting which patients will develop HO is another barrier to effective prevention. This review examines the current state of understanding of post-traumatic HO including the historical context, epidemiology, pathophysiology, clinical issues, currently prophylaxis and detection, management, and potential future approaches. Our aims are to highlight the current lack of effective means of early detection and prevention of HO after major trauma and to stimulate research into novel solutions to this challenging problem. ß
Heterotopic ossification (HO) is the pathological formation of bone in soft tissues. Despite being first described in very early medical literature 1,2 approximately 1000 years ago, this condition still poses significant problems in modern times, most notably amongst military combat casualties (Fig. 1) . The relationship between military injuries and HO was first discussed in the medical literature of the American civil war. 3 Damanski describes how, subsequent to this early description, multiple accounts of HO appeared in the medical literature describing civilian and military occurrences of this condition under various names such as myositis ossificans, ostiasis neurotica para-articularis, paraossalis, and ossifying myopathy. [4] [5] [6] [7] [8] [9] Writing about experience gained in the First World War, Colonel E G Brackett wrote a description of the macroscopic appearance and development of HO that would be familiar to those in the field today:
"Excessive terminal bone production in. . . stumps was the rule. The most common form was an irregular mushrooming with a tendency to spurs on the inner aspect of the femur. Occasionally sharp exostoses were seen. These often were sharp enough and long enough to cause sufficient pain to warrant their removal." 10 The recent conflicts in Iraq and Afghanistan have provided further examples of how HO can present a significant challenge as a consequence of combat injury. The burden of HO has been so great that Alfieri et al. have described it as an "epidemic" and argue that it is the single biggest barrier to functional recovery for combat-injured patients. 11 Genetic Forms of HO HO may be caused by genetic or acquired factors. The genetic forms of HO are not the focus of this review but have relevance due to historical attempts to treat them and the insights that they provide into pathological bone formation. The pathological mechanism that causes the genetic form of HO known as fibrodysplasia ossificans progressiva (FOP) (Fig. 2 ) has been studied extensively and is well characterized: A heterozygous single nucleotide substitution of arginine to histidine (R206H) in the activin A type I receptor (ACVR1) gene. 12, 13 This gene encodes for the protein activin-like kinase 2 (ALK2), which is a receptor for bone morphogenic proteins (BMPs). ALK2 R206H has greater sensitivity to the ligand, BMP-2, leading to increased phosphorylation and nuclear localization of SMAD proteins, and increased Id1 promoter activity.
14 Increased ALK2 activity subsequently leads to increased chondrogenic and osteogenic differentiation and the formation of bone in ectopic sites through endochondral ossification.
In contrast to FOP, progressive osseous heteroplasia (POH) occurs through intramembranous ossification and its genetic basis is less well characterized but is thought to involve heterozygous mutations in the GNAS1 (guanine nucleotide binding protein alpha stimulating) gene. 15 The mutation inactivates the GNAS1 gene, which encodes for the alpha subunit of Gsa, and it is thought that this leads to dysregulation of cell lineage switching, resulting in excessive osteogenic differentiation of mesenchymal stem cells (MSCs).
Post Traumatic HO HO may develop after almost any significant injury but is particularly common after blast injury, high-energy transfer gunshot wounds, central nervous system injury, burns, hip replacement surgery, acetabular fractures, and elbow injuries. It is not clear whether a single common cellular and biochemical mechanism is responsible for the development of HO secondary to each of these causative events.
Epidemiology of Post-Traumatic HO Radiological evidence of HO was found in 64.6% of a cohort of combat injured patients. 17 A similar figure of 62.9% is reported in a series of combat-injured patients who had undergone amputations. 18 In the blast injury subset of these cases, where amputation was performed through the zone of injury, the rate of radiographically moderate or severe HO rose to 79.6%. It is worth noting that in the Afghanistan conflict, from 2003 to 2014, British service personnel suffered 416 combat amputations from 265 patients (giving the mean limbs lost per patient as 1.6). 19 A retrospective observational study of civilian amputations demonstrated that 22.8% of patients developed symptomatic HO. 20 HO is also common amongst patients with traumatic brain injury (radiological evidence in 37% of patients), 21 spinal cord injury (5-60%), 22 hip arthroplasty (5%), 23 distal humerus fractures (8.6%), 24 and burns (0.15%). 25 Leading researchers in the field have commented that the incidence of HO has been much higher in the cohort of injured combatants from the Iraq and Afghanistan conflicts compared to historical data. Potter et al. propose that the reasons for this increase in HO include a high incidence of blast injury (due to increased use of explosive weaponry) and increased survival amongst seriously injured combatants (due to improvements in body armor, medical care, forward surgical treatment, and rapid evacuation). 26 Thus the combination of exposure to blast, 11 extremity amputation, 27, 28 and improved survival 29 ( Fig. 3 ) is thought to have generated an extent and severity of HO not seen before. Historically, patients with these injuries would not have survived long enough to develop symptomatic HO after combat trauma.
Clinical Impact of Post-Traumatic HO Patients with HO experience a wide range of problems due to the mechanical effects of hard tissue in extraskeletal sites. These include pain, loss of joint range of motion, joint ankylosis, skin ulceration, overlying skin graft failure, muscle entrapment, neurovascular entrapment, and prosthetic limb fitting difficulties. 30 Evriviades et al. described the clinical impact of HO on patients eloquently as follows:
"The development of HO can occur in the soft tissues very early and is sometimes found even before primary healing occurs. However, in the majority, it occurs after a number of months. The patient will typically have had an [improvised explosive device] injury and sustained bilateral traumatic above-knee amputations (often with other significant injuries), and will have initially done well with limb fitting and mobilization. They may develop increasing pain in their stumps and can often feel a hard lump or spike within the stump. In severe cases, the bone has actually eroded through the soft tissues. This may prevent them from mobilizing and poses a significant challenge to the prosthetics team."
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Given the high prevalence of HO after civilian and combat-related limb amputations, it is worth noting the problems that these patients have with limb fitting. In the civilian setting, 50% of patients with HO require prosthetic modifications such as selective padding, hard socket reshaping, or new socket fabrication. 20 In the military setting, there are no published data on the proportion of patients requiring prosthetic modification due to HO. However, Pascale and Forsberg et al. clearly describe how HO causes a significant clinical burden for this cohort including activity modification and socket or liner adjustment. 32, 33 Financial Cost of Post-Traumatic HO There are no published data on the direct financial costs of HO. However, some indication may be gained from a paper by Masini et al. who estimate that the direct cost of disability benefits for US service personnel with extremity injury sustained during the campaigns in Iraq and Afghanistan between October 2001 and 2005 to be $1.2 billion. 34 Given that more than 10 years of conflict continued after the publication of that report, the true figure is likely to be vastly more than this estimation. If 64% of combat extremity injuries develop HO (see above), the proportion of this cost estimate that relates to HO prevention, treatment, and rehabilitation is likely to be substantial.
Another analysis, looking at the long term financial cost associated with UK military amputees has identified that approximately £288 million will be required over the next 40 years. 19 Again, this analysis does not specifically estimate the contribution that HO will make to this total figure but it illustrates that the magnitude of the financial cost in addition to the clinical and personal burden to the individuals.
Current Prophylaxis
There are currently no methods of primary prophylaxis that are entirely appropriate for the military population who are likely to be catabolic, at risk of gastric ulceration and renal injury, have open wounds and fractures, and are often in austere environments.
Non-Steroidal Anti Inflammatory Drugs (NSAIDs)
NSAIDs are used widely in civilian practice to cover a variety of situations where patients are at high risk of developing HO. 35 An example is revision total hip replacement surgery where the patient has demonstrable HO secondary to the initial operation. However, there is evidence that, in addition to their normal side effect profile, NSAIDs increase the risk of non-union in the setting of HO prophylaxis after acetabular fixation. 36 Impairment of fracture healing would be a particularly problematic side-effect in major trauma patients as they are highly likely to have sustained at least one fracture as part of their pattern of injuries. Further, these patients are likely to have high risk of kidney injury, which is a major contraindication to NSAID use. 37 
Radiotherapy
Radiotherapy is also used in the elective civilian setting and has been shown to be effective but there is lack of consensus on timing and dose. 38 Radiotherapy and NSAIDs may be given in combination for highrisk patients. 39 There is a paucity of data to guide the use of radiotherapy in the traumatic injury cohort. Even if there was good evidence, the logistical challenges to delivering radiotherapy in austere environments are considerable. Further, there are multiple adverse effects of radiotherapy such as impaired NISS values associated with a predicted 50% or greater probability of survival. These data demonstrate a year-on-year improvement in survival during these armed conflicts. By the later stages, a significant proportion of the most seriously injured patients (NISS ¼ 75) survived. Thus, the increased incidence of HO may be explained, at least in part, by these very seriously injured survivors. Reproduced (creative commons) from Penn-Barwell et al. 27 POST-TRAUMATIC HETEROTOPIC OSSIFICATION 1063 wound and bone healing, which mean that it would be contraindicated in military patients who often have co-synchronous fractures and extremely challenging soft tissue wounds. For example, Hamid et al. have demonstrated that a single-fraction dose of radiotherapy (700 cGy) given to elbow trauma patients as prophylaxis against HO was associated with a nearly 10-fold increase in the rate of non-union. 40 
Bisphosphonates
Bisphosphonates are a class of drugs whose primary use is to prevent and treat osteoporosis. They have also been prescribed as prophylaxis against HO. However, their use remains controversial after a Cochrane review 41 and other studies 42 failed to find conclusive evidence of efficacy. There have been no studies looking at their role after major trauma.
Passive Movement Therapy
Another Cochrane review 43 investigating the use of passive movement physiotherapy in a heterogeneous group of patients (including traumatic brain injury and spinal cord injury patients at risk of HO) concluded that there is insufficient evidence show whether or not this therapy is effective.
Experimental Prophylaxis
One strategy that has shown immense promise is retinoic acid receptor gamma (RARg) agonism to inhibit chondrogenesis. 44 Without a cartilage scaffold, the endochondral processes that form HO are blocked and no mineral can be deposited. It is worth noting that, in the rodent model, there was a transient prolongation of fracture healing associated with RARg agonism. Despite this concern, the treatment was so effective that the RARg agonist palovarotene has been taken forward into clinical trials (NCT02279095) as a treatment for FOP. 45 Another novel strategy has been demonstrated in a burn-tenotomy rodent HO model 46 whereby hydrolysis of adenosine triphosphate (ATP) at the burn site led to reduced HO formation at a distant site. In addition to revealing a potential therapeutic strategy, this "remote ATP hydrolysis" method provides a further mechanistic insight into the role of phosphorylated SMAD proteins in the development of HO.
In another rodent tenotomy model (without burn injury), treatment with the antibiotic echinomycin inhibited HO formation. 47 The proposed mechanism is that echinomycin inhibits hypoxia-induced factor 1-a (HIF-1-a), a signalling molecule thought to be crucial to the process of chondrogenic differentiation of mesenchymal stem cells in HO.
Further evidence of the potential of antibiotic drugs to prevent HO comes from recent work in a rodent high-energy extremity trauma model. 48 Early topical vancomycin reduced the burden of HO in this model, independent of whether or not the wound was infected. As with the work using echinomycin (above), this suggests that the relevant action of vancomycin is not mediated through its antibiotic activity.
It is important to note that all of the experimental and extant prophylaxes work by attempting to inhibit the cellular and/or biochemical pathways that are thought to cause HO. There are no published data on experimental or clinical treatments that have been designed to directly inhibit or disperse the mineral component of heterotopic ossification.
Current Treatment
Non-Operative Management Rest, analgesia, nerve blocks, and nerve ablations form the mainstay of non-surgical treatments. 11 However, once HO has formed and matured, it has not been shown to regress or remodel significantly, so patients who remain symptomatic after optimization of non-surgical management options will often require surgery.
Operative Management
In a civilian amputation study, 25% of patients were treated with NSAIDS, 8% with bisphosphonates, and 11% underwent surgery to resect the ectopic bone. 20 In a series of military patients, 19% required surgical excision, with a mean interval between injury and excision of 8.2 months. 18 Excision had a significant effect on the analgesic requirements of the patients: 63% were able to cease opioid analgesia completely. There is debate about the exact timing of surgery. If HO is excised too early then it may recur but waiting too long may delay the patient's rehabilitation and return to function. A systematic review of studies of HO excision after brain injury did not find evidence to support the view that early surgery predisposes to recurrence. 49 With appropriate timing of surgery and secondary prophylaxis with NSAIDS and/or radiotherapy, recurrence of HO rarely requires further surgery. For example, in a large series of patients who had undergone primary HO excision secondary to acquired brain or spinal cord injury, only 5.8% required further surgery due to recurrence. 22 Recent practice for secondary prophylaxis amongst UK military surgeons excising HO has been to prescribe a 4-week course of oral indomethacin (with concomitant gastric protection such as a proton pump inhibitor) starting in the immediate post-operative period. 31 Potter et al. have reported that high quality evidence to guide the choice of secondary prophylaxis is lacking. 18 Despite the success of operative interventions in controlling HO, it must be stressed that these operations are technically extremely challenging and come with significant risks of adverse events such as bleeding and damage to remaining soft tissues. 31 Standard practice at the UK Defence Medical Rehabilitation Centre, Headley Court, is that amputee patients are non-weight bearing for 6 weeks after surgery to their stumps (personal communication). Given that these patients can have multiple operations for soft tissue reconstruction, any additional requirement for surgery due to HO excision can add to their 1064 EISENSTEIN ET AL. already significant period of non-weight bearing and this can have lasting effects on their rehabilitation potential.
Pathophysiology

Signalling and Cellular Factors
There is significant controversy in the literature about the fundamental cellular and molecular mechanisms involved in acquired HO formation. [50] [51] [52] Candidate cell populations of mesodermal, ectodermal, and endodermal origin have all been proposed. 53, 54 One of the key problems is that while there are many cell types that may be influenced to produce mineralization in vitro or in vivo, this does not mean that they are responsible for HO in patients. Davies et al. 55 reviewed the evidence for and against all of these candidates and concluded that it is most likely that HO results from complex signalling networks involving multiple cell types (Fig. 4) . However, consensus is building to favor the direct role of multipotent cells of mesenchymal origin. 56 One example of how intercellular signalling is important in the formation of HO comes from the work of Olmsted-Davis et al. 57 They used a mouse bone morphogenic protein (BMP-2) model to demonstrate that hypoxic adipocytes were required for the differentiation of stem cells to chondrocytes, which is a key early step in the formation of ectopic bone. In addition to illustrating the role of multiple cell populations in the formation of HO, this work demonstrates that local physicochemical environment may play a role. Tissue hypoxia may not only stimulate intercellular signalling but will also lead to reduced pH through cellular anaerobic respiration. Low pH will, in turn, have an effect on the chemical phases that are stable in that environment and may even be exploited for the purposes of preventing and treating HO.
Recent work has provided evidence that different cell types may even generate phenotypically distinct HO subtypes. In an Acvr1
R206H knock in mouse model that phenotypically resembles the genetic from of HO (FOP), Mx1 + cells produced injury-dependent intramuscular HO whereas Scx + cells lead to injury-independent ossification of ligaments and tendons. 58 The Role of Inflammation There is significant support in the clinical 59, 60 and basic science 61 literature for the central role of an exaggerated inflammatory response in the pathogenesis of HO. It is well recognized that patients who have suffered major trauma demonstrate a multiphasic inflammatory dysregulation after injury with both acute and chronic components. 62, 63 This seems to fit with the observed clinical experience of HO in a number of interesting ways. It might explain why HO develops after weeks to months and then progresses for months to years, after which time it stabilizes and becomes quiescent. 50 It may also explain why the timing of excision surgery is important if recurrence is to be avoided. 64 This inflammation hypothesis is supported by the most comprehensive work to date characterizing the effect of timing of surgery on HO recurrence, which recommended that at least 180 days should elapse between injury and attempted complete excision. 65 Ossification Mechanism in HO It has been shown that there is upregulation in key osteogenic and chondrogenic gene transcripts (BMP2, BMP3, ALPL, COLL2A1, COLL10A1, COLL11A1, COMP, CSF2, CSF3, MMP8, MMP9, SMAD1, and VEGFA) in the soft tissues of high-energy combat wounds. 66 The upregulation of these gene transcripts suggests an endochondral (as opposed to an intramembranous) model of development of acquired HO, something that has been confirmed separately in an animal model. 67, 68 Early Detection Currently, HO is diagnosed using imaging techniques. However, significant benefits may be gained by earlier identification and better risk stratification of those patients who will go on to develop HO. Reliable risk stratification and prediction allows clinicians to target prophylactic therapies at the right patients thus reducing the risk of harmful side effects in those who would never have developed HO anyway. The increasing knowledge of cellular and biochemical pathophysiology of this condition has allowed the development of several techniques that set out to achieve this goal. For example, one group has shown that serum levels of interleukin (IL) 3 and 12p70 and wound effluent levels of IL-3 and 13 at the time of first debridement predicted those would go on to develop HO. 59, 60 However, it must be noted that these studies have not been validated in a civilian population and the authors stress that the complex interrelationship between the inflammatory markers remains incompletely understood.
The same gene expression data that was used to demonstrate that HO forms through endochondral ossification could also be used as a predictor of HO in combat wounds. 66 There was a significant difference in the transcriptional activity of key osteogenesis-related genes between patients that developed HO and those who did not. This study may, however, be confounded by the finding that the HO group had a significantly higher injury burden, more bacterial colonization, bigger wounds, and more amputations than the non-HO group.
DISCUSSION
Post-Traumatic HO is a fascinating and debilitating condition (or perhaps group of conditions) that has been known about for a long time. For many years it has been regarded as a rare complication of central nervous system injury or an inconvenient adverse effect of major surgery and so a handful of prophylactic approaches were discovered and developed to attempt to prevent it in those settings. However, since 2003, with the beginning of the conflicts in Iraq and Afghanistan and the subsequent on-going unrest in the region, our experience of this condition has changed completely. This is due to the alignment of a unique set of circumstances: Increased incidence of blast injuries, increased incidence of combat-related amputations, and vast improvement in survival of even the most seriously injured patients. The result of this is that we have seen a significant increase in both the incidence and severity of this disease. The few prophylaxes that had been developed to prevent HO in the civilian setting have been shown to be either ineffective or inappropriate for the complex and often multiply injured military casualties, who are thus left at high risk of developing HO. Furthermore, even if we had an effective prevention strategy, early reliable detection and risk stratification is not yet available to guide administration of such and intervention. Despite their severe injuries, these patients have been shown to have a high potential for good functional outcome with appropriate rehabilitation. 69, 70 However, it has been claimed that the single biggest barrier to achieving this potential is HO. This is because not only does it prevent patients from using the highly advanced prosthetics that are made available to them but also because the surgery required to excise HO introduces multiple long delays into their rehabilitation, which have a cumulative deleterious effect on their final functional outcome.
CONCLUSIONS
Post-traumatic HO represents a significant threat to the rehabilitation potential of patients after major injury. There is an unmet need for improvements in early detection, risk stratification, and effective prophylaxis in this cohort. Promising progress has been made in all of these areas but no new solutions have made their way to clinical practice yet. The time to drive progress in this area is now, so that when the next major conflict emerges, we are prepared to counter this age-old problem with brand new approaches.
